The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Harvoni® (ledipasvir and sofosbuvir) and Hepatitis C

How can I get assistance paying for Harvoni®? Is Harvoni® covered by insurance?

UPDATE: In 2019 Gilead, the developer of Epclusa, authorized a generic version of Harvoni.

Gilead, states that they are committed to ensuring patients with Hepatitis C can access Harvoni® and they have created a Support Path™ to provide assistance to patients who are uninsured, underinsured or need financial assistance to pay for Harvoni®. For more information visit

Additionally, Gilead is providing a co-pay coupon to pay no more than $5 per co-pay for those that are eligible. For more details and to register visit

Contact your insurance company directly for information regarding coverage of Harvoni®.

Last Updated: January 2019

"FDA Drug Safety Communication: FDA Warns of Serious Slowing of the Heart Rate When Antiarrhythmic Drug Amiodarone is Used with Hepatitis C Treatments Containing Sofosbuvir (Harvoni) or Sovaldi in Combination with Another Direct Acting Antiviral Drug." U.S. Food and Drug Administration, Retrieved April 10, 2015.

"Full Prescribing Information." Gilead Sciences, Inc., Retrieved April 10, 2015.

"Harvoni® Coupon and Savings." Gilead Sciences, Inc., Retrieved April 13, 2015.

"Patient Information: Harvoni®." Gilead Sciences, Inc., Retrieved April 13, 2015.

"Support Path Harvoni® and Sovaldi® Tablets Treatment Support." Gilead Sciences, Inc., Retrieved April 13, 2015.